These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31506329)

  • 1. Reshaping cAMP nanodomains through targeted disruption of compartmentalised phosphodiesterase signalosomes.
    Blair CM; Baillie GS
    Biochem Soc Trans; 2019 Oct; 47(5):1405-1414. PubMed ID: 31506329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of Compartmentalised Cyclic Nucleotide Signalling via Local Inhibition of Phosphodiesterase Activity.
    Brescia M; Zaccolo M
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27706091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optical Mapping of cAMP Signaling at the Nanometer Scale.
    Bock A; Annibale P; Konrad C; Hannawacker A; Anton SE; Maiellaro I; Zabel U; Sivaramakrishnan S; Falcke M; Lohse MJ
    Cell; 2020 Sep; 182(6):1519-1530.e17. PubMed ID: 32846156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PDE2 at the crossway between cAMP and cGMP signalling in the heart.
    Weber S; Zeller M; Guan K; Wunder F; Wagner M; El-Armouche A
    Cell Signal; 2017 Oct; 38():76-84. PubMed ID: 28668721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic nucleotide phosphodiesterase (PDE) inhibitors: novel therapeutic agents for progressive renal disease.
    Cheng J; Grande JP
    Exp Biol Med (Maywood); 2007 Jan; 232(1):38-51. PubMed ID: 17202584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo assessment of local phosphodiesterase activity using tailored cyclic nucleotide-gated channels as cAMP sensors.
    Rich TC; Tse TE; Rohan JG; Schaack J; Karpen JW
    J Gen Physiol; 2001 Jul; 118(1):63-78. PubMed ID: 11429444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental and mathematical analysis of cAMP nanodomains.
    Lohse C; Bock A; Maiellaro I; Hannawacker A; Schad LR; Lohse MJ; Bauer WR
    PLoS One; 2017; 12(4):e0174856. PubMed ID: 28406920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of cyclic nucleotide phosphodiesterases with cyclic AMP analogs: topology of the catalytic sites and comparison with other cyclic AMP-binding proteins.
    Butt E; Beltman J; Becker DE; Jensen GS; Rybalkin SD; Jastorff B; Beavo JA
    Mol Pharmacol; 1995 Feb; 47(2):340-7. PubMed ID: 7870042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Channeling of cAMP in PDE-PKA Complexes Promotes Signal Adaptation.
    Tulsian NK; Krishnamurthy S; Anand GS
    Biophys J; 2017 Jun; 112(12):2552-2566. PubMed ID: 28636912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "cAMP-specific" phosphodiesterase contributes to cGMP degradation in cerebellar cells exposed to nitric oxide.
    Bellamy TC; Garthwaite J
    Mol Pharmacol; 2001 Jan; 59(1):54-61. PubMed ID: 11125024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of phosphodiesterase IV activity and its cyclic adenosine monophosphate-dependent up-regulation in a human keratinocyte cell line (HaCaT).
    Tenor H; Hatzelmann A; Wendel A; Schudt C
    J Invest Dermatol; 1995 Jul; 105(1):70-4. PubMed ID: 7615979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting cancer with phosphodiesterase inhibitors.
    Savai R; Pullamsetti SS; Banat GA; Weissmann N; Ghofrani HA; Grimminger F; Schermuly RT
    Expert Opin Investig Drugs; 2010 Jan; 19(1):117-31. PubMed ID: 20001559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic nucleotide-mediated regulation of vascular smooth muscle cell cyclic nucleotide phosphodiesterase activity. Selective effect of cyclic AMP.
    Maurice DH
    Cell Biochem Biophys; 1998; 29(1-2):35-47. PubMed ID: 9631237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphodiesterase Diversity and Signal Processing Within cAMP Signaling Networks.
    Neves-Zaph SR
    Adv Neurobiol; 2017; 17():3-14. PubMed ID: 28956327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions.
    Soderling SH; Beavo JA
    Curr Opin Cell Biol; 2000 Apr; 12(2):174-9. PubMed ID: 10712916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanodomain Regulation of Cardiac Cyclic Nucleotide Signaling by Phosphodiesterases.
    Kokkonen K; Kass DA
    Annu Rev Pharmacol Toxicol; 2017 Jan; 57():455-479. PubMed ID: 27732797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compartmentalized signalling: spatial regulation of cAMP by the action of compartmentalized phosphodiesterases.
    Baillie GS
    FEBS J; 2009 Apr; 276(7):1790-9. PubMed ID: 19243430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic nucleotide signalling compartmentation by PDEs in cultured vascular smooth muscle cells.
    Zhang L; Bouadjel K; Manoury B; Vandecasteele G; Fischmeister R; Leblais V
    Br J Pharmacol; 2019 Jun; 176(11):1780-1792. PubMed ID: 30825186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PDE 2015: cAMP Signaling, Protein Kinase A (PKA) and Phosphodiesterases (PDEs): How Genetics Changed the Way We Look at One of the Most Studied Signaling Pathways.
    Stratakis CA; Kelestimur F; Bertherat J
    Horm Metab Res; 2017 Apr; 49(4):237-239. PubMed ID: 28427096
    [No Abstract]   [Full Text] [Related]  

  • 20. Underpinning compartmentalised cAMP signalling through targeted cAMP breakdown.
    Houslay MD
    Trends Biochem Sci; 2010 Feb; 35(2):91-100. PubMed ID: 19864144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.